Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yufeining is a Traditional Chinese Medicine (TCM) herbal prescription developed by the Zhangzhou Hospital of Traditional Chinese Medicine for the treatment of chronic obstructive pulmonary disease (COPD). It is typically used in patients with stable COPD to improve clinical symptoms, enhance exercise tolerance, and improve overall quality of life. The mechanism of action involves the regulation of immunological functions, specifically targeting the balance of inflammatory cytokines and immune cell populations to reduce chronic airway inflammation. Clinical research has focused on its ability to modulate the immune response and improve the respiratory health of patients with chronic lung conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yufeining.